Conditions: Acute Coronary Syndrome
Keywords: NOS
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 7484
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if apixaban is superior to placebo for preventing cardiovascular death, non-fatal myocardial infarction, or ischemic stroke in subjects with a recent acute coronary syndrome

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Apixaban intervention 2: Placebo
Intervention descriptions: intervention 1: Tablets, Oral, 5 mg, twice daily, until study end intervention 2: Tablets, Oral, 0 mg, twice daily, until study end

Protocol document: